Imago BioSciences
(NASDAQ) IMGO
Imago BioSciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$62.62M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IMGO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Imago BioSciences
Industry
Biotechnology
Sector
Health CareEmployees
27
CEO
Hugh Young Rienhoff, Jr., MD
Website
www.imagobio.comHeadquarters
South San Francisco, CA 94080, US
IMGO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-58%
Return on Capital
-20%
Return on Assets
-19%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$41.99M
EBITDA
$42.52M
Operating Cash Flow
$39.76M
Capital Expenditure
$0.00
Free Cash Flow
$39.76M
Cash & ST Invst.
$217.41M
Total Debt
$0.00
Imago BioSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
41
N/A
Net Income
$17.55M
-50.4%
EBITDA
$17.56M
-49.8%
Quarterly Fundamentals
Net Cash
$178.41M
-22.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-18.82%
N/A
Return on Invested Capital
-19.56%
N/A
Free Cash Flow
$11.72M
+4.2%
Operating Cash Flow
$11.72M
+4.2%